VCM
BIIB icon

Virtue Capital Management’s Biogen BIIB Stock Holding History

Virtue Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,508
Closed -$206K – 274
2025
Q1 		$206K Buy
1,508
+8
+0.5% +$1.14K 0.02% 448
2024
Q4 		$229K Buy
+1,500
New +$253K 0.05% 224
2018
Q2 		– Sell
-200
Closed -$52K – 224
2018
Q1 		$52K Buy
+200
New +$62.1K 0.03% 255

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtue Capital Management's BIIB Position: Q2 2025 in Review

Virtue Capital Management sold out of Biogen (BIIB) in Q2 2025, closing a stake of 1,508 shares — an estimated $206K sold.

Virtue Capital Management first reported a position in BIIB in Q1 2018 and held it in 3 quarters. The position peaked at $229K in Q4 2024. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Virtue Capital Management reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Virtue Capital Management sold 1,508 Biogen shares in Q2 2025, an estimated $206K.
  • Virtue Capital Management first reported a position in Biogen in Q1 2018 and held it in 3 quarters.
  • Virtue Capital Management's Biogen position peaked at $229K in Q4 2024.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Virtue Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.